169 related articles for article (PubMed ID: 32356328)
1. Gastric subtype of intraductal papillary neoplasm of the bile duct: The pathologic spectrum.
Nakanuma Y; Uesaka K; Terada T; Fukumura Y; Sugino T; Kakuda Y; Ikeda H; Harada K; Sato Y; Shimizu S; Matsukuma S; Kee Taek J; Nyun Park Y
J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):402-413. PubMed ID: 32356328
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
[TBL] [Abstract][Full Text] [Related]
3. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
Rocha FG; Lee H; Katabi N; DeMatteo RP; Fong Y; D'Angelica MI; Allen PJ; Klimstra DS; Jarnagin WR
Hepatology; 2012 Oct; 56(4):1352-60. PubMed ID: 22504729
[TBL] [Abstract][Full Text] [Related]
4. Reappraisal of pathological features of intraductal papillary neoplasm of bile duct with respect to the type 1 and 2 subclassifications.
Nakanuma Y; Uesaka K; Okamura Y; Terada T; Fukumura Y; Kakuda Y; Sugino T; Sato Y; Taek JK; Park YN
Hum Pathol; 2021 May; 111():21-35. PubMed ID: 33508254
[TBL] [Abstract][Full Text] [Related]
5. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.
Nakanuma Y; Jang KT; Fukushima N; Furukawa T; Hong SM; Kim H; Lee KB; Zen Y; Jang JY; Kubota K
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):181-187. PubMed ID: 29272078
[TBL] [Abstract][Full Text] [Related]
6. Characterization of intraductal papillary neoplasm of bile duct with respect to histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm.
Nakanuma Y; Kakuda Y; Uesaka K; Miyata T; Yamamoto Y; Fukumura Y; Sato Y; Sasaki M; Harada K; Takase M
Hum Pathol; 2016 May; 51():103-13. PubMed ID: 27067788
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm.
Nakanuma Y; Kakuda Y; Uesaka K
Gut Liver; 2019 Nov; 13(6):617-627. PubMed ID: 30982236
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
[TBL] [Abstract][Full Text] [Related]
9. [Intraductal papillary neoplasms of intrahepatic bile duct: a clinicopathologic study of 25 cases].
Chang XY; Li J; Ren XY; Zhou WX; Chen J
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):243-7. PubMed ID: 27033387
[TBL] [Abstract][Full Text] [Related]
10. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.
Lim JH; Zen Y; Jang KT; Kim YK; Nakanuma Y
AJR Am J Roentgenol; 2011 Nov; 197(5):1111-20. PubMed ID: 22021503
[TBL] [Abstract][Full Text] [Related]
11. The Pathologic and Genetic Characteristics of the Intestinal Subtype of Intraductal Papillary Neoplasms of the Bile Duct.
Nakanuma Y; Kakuda Y; Fukumura Y; Sugino T; Uesaka K; Serizawa M; Terada T; Ohnishi Y
Am J Surg Pathol; 2019 Sep; 43(9):1212-1220. PubMed ID: 31166202
[TBL] [Abstract][Full Text] [Related]
12. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
[TBL] [Abstract][Full Text] [Related]
13. [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].
Schlitter AM; Klöppel G; Esposito I
Pathologe; 2013 Nov; 34 Suppl 2():235-40. PubMed ID: 24196621
[TBL] [Abstract][Full Text] [Related]
14. Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct.
Yang CY; Huang WJ; Tsai JH; Cheng A; Chen CC; Hsu HP; Jeng YM
Mod Pathol; 2019 Nov; 32(11):1637-1645. PubMed ID: 31231124
[TBL] [Abstract][Full Text] [Related]
15. Intraductal tubular adenoma of the pancreas as a possible rare variant of gastric-type intraductal papillary mucinous neoplasm: a report of two cases.
Teng X; Xue D; Lai M
Anal Quant Cytopathol Histpathol; 2012 Dec; 34(6):325-30. PubMed ID: 23304818
[TBL] [Abstract][Full Text] [Related]
16. Intraductal papillary neoplasm of the bile duct.
Wan XS; Xu YY; Qian JY; Yang XB; Wang AQ; He L; Zhao HT; Sang XT
World J Gastroenterol; 2013 Dec; 19(46):8595-604. PubMed ID: 24379576
[TBL] [Abstract][Full Text] [Related]
17. Intraductal tubular neoplasms of the bile ducts.
Katabi N; Torres J; Klimstra DS
Am J Surg Pathol; 2012 Nov; 36(11):1647-55. PubMed ID: 23073323
[TBL] [Abstract][Full Text] [Related]
18. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.
Aoki Y; Mizuma M; Hata T; Aoki T; Omori Y; Ono Y; Mizukami Y; Unno M; Furukawa T
J Pathol; 2020 May; 251(1):38-48. PubMed ID: 32100878
[TBL] [Abstract][Full Text] [Related]
19. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Study of Resections of Intraductal Papillary Neoplasm of the Bile Duct.
Sato T; Hisaka T; Sakai H; Ishikawa H; Kawahara R; Goto Y; Nomura Y; Yasunaga M; Fujita F; Tanigawa M; Naito Y; Akiba J; Yano H; Tanaka H; Akagi Y; Okuda K
Anticancer Res; 2019 Aug; 39(8):4569-4573. PubMed ID: 31366561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
